Literature DB >> 18082412

A microRNA-based gene dysregulation pathway in Huntington's disease.

Rory Johnson1, Chiara Zuccato, Nikolai D Belyaev, Deborah J Guest, Elena Cattaneo, Noel J Buckley.   

Abstract

Huntington's disease (HD) is a dominantly-inherited neurodegenerative disorder which is incurable and ultimately fatal. HD is characterised by widespread mRNA dysregulation, particularly in neurons of the forebrain, by mechanisms which are not fully understood. Such dysregulation has been demonstrated to result, in part, from aberrant nuclear localisation of the transcriptional repressor, REST. Here, we show that expression of a number of neuronal-specific microRNAs is also dysregulated in HD tissues, probably as a result of increased repression by REST. This phenomenon is observed in both murine models of HD and in the brains of human HD sufferers. MicroRNA loss is reflected in increased levels of a number of target messenger RNAs. These data are the first to demonstrate a role for microRNAs in HD, and indicate that the molecular aetiology of HD is reflected in a loss of neuronal identity, caused in part by dysregulation of both transcriptional and post-transcriptional mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082412     DOI: 10.1016/j.nbd.2007.11.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  158 in total

Review 1.  General principals of miRNA biogenesis and regulation in the brain.

Authors:  Dónal O'Carroll; Anne Schaefer
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions.

Authors:  Irfan A Qureshi; Solen Gokhan; Mark F Mehler
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

Review 3.  Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

Authors:  Huiping Tan; Zihui Xu; Peng Jin
Journal:  Exp Neurol       Date:  2012-01-27       Impact factor: 5.330

Review 4.  The interplay between microRNAs and histone deacetylases in neurological diseases.

Authors:  Megan W Bourassa; Rajiv R Ratan
Journal:  Neurochem Int       Date:  2014-03-27       Impact factor: 3.921

Review 5.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

6.  Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

Authors:  Rui-chao Zeng; Wei Zhang; Xing-qiang Yan; Zhi-qiang Ye; En-dong Chen; Du-ping Huang; Xiao-hua Zhang; Guan-li Huang
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

7.  miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice.

Authors:  Fenghua Zhou; Yingjun Guan; Yanchun Chen; Caixia Zhang; Li Yu; Hailing Gao; Hongmei Du; Bing Liu; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 8.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 9.  Understanding microRNAs in neurodegeneration.

Authors:  Stephen M Eacker; Ted M Dawson; Valina L Dawson
Journal:  Nat Rev Neurosci       Date:  2009-11-11       Impact factor: 34.870

10.  Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin.

Authors:  Jing Jin; Yong Cheng; Yongqing Zhang; William Wood; Qi Peng; Emmette Hutchison; Mark P Mattson; Kevin G Becker; Wenzhen Duan
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.